Akero Therapeutics, Inc.

AKRO

Find Out if You Qualify for a Financial Reward by filling out the form below.

Akero Therapeutics, Inc. Form












Stock Fraud Law Center does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

On October 10, 2023, AKRO announced Efruxifermin (EFX) failed to meet the primary endpoint of fibrosis improvement at 36 weeks in the Phase 2B SYMMETRY trial in NASH patients with compensated cirrhosis. The Company’s President and CEO stated “we set a high bar with the primary endpoint after only 36 weeks of treatment.” Analysts noted that they were surprised at the 36 week miss and the study design may have stretched EFX too far.

Following this news, AKRO’s stock price fell by $30.39 per share, or approximately 63% to close at $18.15 per share.

Active Cases

Ticker Symbol Company Name Join Deadline Join
PANW Palo Alto Networks Inc. April 26, 2024 Join
KIND Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II April 29, 2024 Join
PLCE The Children's Place, Inc. April 29, 2024 Join
SNOW Snowflake Inc. April 29, 2024 Join
VTYX Ventyx Biosciences, Inc. April 30, 2024 Join
IRBT iRobot Corporation May 07, 2024 Join
AVXL Anavex Life Sciences Corporation May 13, 2024 Join
000 Next Bridge Hydrocarbons, Inc. May 14, 2024 Join
INVZ Innoviz Technologies Ltd. May 14, 2024 Join
SSRM SSR Mining Inc. May 17, 2024 Join
AGL agilon health, inc. May 20, 2024 Join
CC The Chemours Company May 20, 2024 Join
SHLS Shoals Technologies Group, Inc. May 21, 2024 Join
PLUG Plug Power Inc. May 21, 2024 Join
EVLV Evolv Technologies Holdings, Inc. May 24, 2024 Join
BLUE bluebird bio, Inc. May 28, 2024 Join
LUNA Luna Innovations Incorporated May 31, 2024 Join
HRT HireRight Holdings Corporation June 03, 2024 Join
VFS VinFast Auto Ltd. f/k/a Black Spade Acquisition Co. June 11, 2024 Join
QDEL QuidelOrtho Corporation f/k/a Quidel Corporation June 11, 2024 Join
PERI Perion Network Ltd. June 17, 2024 Join
ASTS AST SpaceMobile, Inc. June 17, 2024 Join